Here is what FDA public regulatory sources confirm as of May 2026: The FDA removed tirzepatide from its drug shortage list in December 2024 and semaglutide in February 2025
There are some other more expensive forms such as creatine ethyl ester which have not shown any superior benefit so dont waste your money on different versions
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects
Instead of moving food into the small intestine, the stomach becomes slow, dysfunctional, or completely paralyzed causing chronic nausea, vomiting, abdominal pain, severe bloating, and long-term digestive impairment
These services may make treatment easier to manage, but they do not guarantee a particular amount or speed of weight loss
While Semaglutide works on a single hormone receptor and Tirzepatide works on 2, Retatrutide hits 3 different hormone receptors, which enhances the potency and effectiveness of the agent